Cargando…
Novel Therapeutics for Epstein–Barr Virus
Epstein–Barr virus (EBV) is a human γ-herpesvirus that infects up to 95% of the adult population. Primary EBV infection usually occurs during childhood and is generally asymptomatic, though the virus can cause infectious mononucleosis in 35–50% of the cases when infection occurs later in life. EBV i...
Autores principales: | Andrei, Graciela, Trompet, Erika, Snoeck, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429425/ https://www.ncbi.nlm.nih.gov/pubmed/30871092 http://dx.doi.org/10.3390/molecules24050997 |
Ejemplares similares
-
The Epstein-Barr Virus
por: Payne, L. N.
Publicado: (1980) -
Epstein–barr virus vaccines
por: Cohen, Jeffrey I
Publicado: (2015) -
An MHV-68 Mutator Phenotype Mutant Virus, Confirmed by CRISPR/Cas9-Mediated Gene Editing of the Viral DNA Polymerase Gene, Shows Reduced Viral Fitness
por: Trompet, Erika, et al.
Publicado: (2021) -
Epstein Barr virus-associated lymphoproliferative diseases: the virus as a therapeutic target
por: Tse, Eric, et al.
Publicado: (2015) -
Therapeutic implications of Epstein–Barr virus infection for the treatment of nasopharyngeal carcinoma
por: Hutajulu, Susanna Hilda, et al.
Publicado: (2014)